The metformin research suggests plausibility for similar effects with semaglutide , but the mechanisms differ enough that direct extrapolation remains uncertain
While GLP-1 medications dominate headlines, nutrition and lifestyle strategies that support the bodys own GLP-1 pathways are gaining attention
While Ozempic is not FDA-approved specifically for weight loss, it is often prescribed off-label due to its effectiveness in helping individuals lose weight, particularly those with a BMI of 27+ and weight-related health conditions
Weight loss during this phase is typically the most rapid, with many researchers reporting 1-3% body weight loss per month
Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, et al